Naiara Perurena

Closest collaborators

The 17 strongest of 17 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

1. Douglas Adam Rubinson · 1 shared paper, 2023 · strength 0.14
   • Paper USP9X mediates an acute adaptive response to MAPK suppression in pancreatic cancer but creates multiple actionable ther… DOI 10.1016/j.xcrm.2023.101007↗
2. Srivatsan Raghavan · 1 shared paper, 2023 · strength 0.14
   • Paper USP9X mediates an acute adaptive response to MAPK suppression in pancreatic cancer but creates multiple actionable ther… DOI 10.1016/j.xcrm.2023.101007↗
3. William C. Hahn · 1 shared paper, 2023 · strength 0.14
   • Paper USP9X mediates an acute adaptive response to MAPK suppression in pancreatic cancer but creates multiple actionable ther… DOI 10.1016/j.xcrm.2023.101007↗
4. Andrew J. Aguirre · 1 shared paper, 2023 · strength 0.14
   • Paper USP9X mediates an acute adaptive response to MAPK suppression in pancreatic cancer but creates multiple actionable ther… DOI 10.1016/j.xcrm.2023.101007↗
5. Brian Matthew Wolpin · 1 shared paper, 2023 · strength 0.14
   • Paper USP9X mediates an acute adaptive response to MAPK suppression in pancreatic cancer but creates multiple actionable ther… DOI 10.1016/j.xcrm.2023.101007↗
6. Karen M Cichowski · 1 shared paper, 2023 · strength 0.14
   • Paper USP9X mediates an acute adaptive response to MAPK suppression in pancreatic cancer but creates multiple actionable ther… DOI 10.1016/j.xcrm.2023.101007↗
7. Jennifer P. Morton · 1 shared paper, 2023 · strength 0.14
   • Paper USP9X mediates an acute adaptive response to MAPK suppression in pancreatic cancer but creates multiple actionable ther… DOI 10.1016/j.xcrm.2023.101007↗
8. Owen James Sansom · 1 shared paper, 2023 · strength 0.14
   • Paper USP9X mediates an acute adaptive response to MAPK suppression in pancreatic cancer but creates multiple actionable ther… DOI 10.1016/j.xcrm.2023.101007↗
9. James M. Cleary · 1 shared paper, 2023 · strength 0.14
   • Paper USP9X mediates an acute adaptive response to MAPK suppression in pancreatic cancer but creates multiple actionable ther… DOI 10.1016/j.xcrm.2023.101007↗
10. Adrián Vallejo · 1 shared paper, 2017 · strength 0.05
    • Paper An integrative approach unveils FOSL1 as an oncogene vulnerability in KRAS-driven lung and pancreatic cancer. DOI 10.1038/ncomms14294↗
11. Peter J. Bailey · 1 shared paper, 2017 · strength 0.05
    • Paper An integrative approach unveils FOSL1 as an oncogene vulnerability in KRAS-driven lung and pancreatic cancer. DOI 10.1038/ncomms14294↗
12. Mariano Ponz‐Sarvisé · 1 shared paper, 2017 · strength 0.05
    • Paper An integrative approach unveils FOSL1 as an oncogene vulnerability in KRAS-driven lung and pancreatic cancer. DOI 10.1038/ncomms14294↗
13. Julien Sage · 1 shared paper, 2017 · strength 0.05
    • Paper An integrative approach unveils FOSL1 as an oncogene vulnerability in KRAS-driven lung and pancreatic cancer. DOI 10.1038/ncomms14294↗
14. Silvestre Vicent · 1 shared paper, 2017 · strength 0.05
    • Paper An integrative approach unveils FOSL1 as an oncogene vulnerability in KRAS-driven lung and pancreatic cancer. DOI 10.1038/ncomms14294↗
15. Pawel Karol Mazur · 1 shared paper, 2017 · strength 0.05
    • Paper An integrative approach unveils FOSL1 as an oncogene vulnerability in KRAS-driven lung and pancreatic cancer. DOI 10.1038/ncomms14294↗
16. David Kuang-Fu Chang · 1 shared paper, 2017 · strength 0.05
    • Paper An integrative approach unveils FOSL1 as an oncogene vulnerability in KRAS-driven lung and pancreatic cancer. DOI 10.1038/ncomms14294↗
17. Andrew Victor Biankin · 1 shared paper, 2017 · strength 0.05
    • Paper An integrative approach unveils FOSL1 as an oncogene vulnerability in KRAS-driven lung and pancreatic cancer. DOI 10.1038/ncomms14294↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.